Sandbox Reserved 1606
From Proteopedia
(Difference between revisions)
| Line 51: | Line 51: | ||
Talk about how and why it would be a good target for the treatment of cancer and include paper talking about inhibition of it | Talk about how and why it would be a good target for the treatment of cancer and include paper talking about inhibition of it | ||
| - | + | ||
</StructureSection> | </StructureSection> | ||
Revision as of 01:06, 30 March 2020
| This Sandbox is Reserved from Jan 13 through September 1, 2020 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1598 through Sandbox Reserved 1627. |
To get started:
More help: Help:Editing |
ABCG2 Multidrug Transporter
| |||||||||||
References
- ↑ 1.0 1.1 1.2 Taylor NMI, Manolaridis I, Jackson SM, Kowal J, Stahlberg H, Locher KP. Structure of the human multidrug transporter ABCG2. Nature. 2017 Jun 22;546(7659):504-509. doi: 10.1038/nature22345. Epub 2017 May, 29. PMID:28554189 doi:http://dx.doi.org/10.1038/nature22345
- ↑ 2.0 2.1 Manolaridis I, Jackson SM, Taylor NMI, Kowal J, Stahlberg H, Locher KP. Cryo-EM structures of a human ABCG2 mutant trapped in ATP-bound and substrate-bound states. Nature. 2018 Nov;563(7731):426-430. doi: 10.1038/s41586-018-0680-3. Epub 2018 Nov, 7. PMID:30405239 doi:http://dx.doi.org/10.1038/s41586-018-0680-3
